Former Nordion CEO Steve West has been appointed to the board of directors of TSO3, the Quebec City-based company announced Tuesday.
TSO3 (TSE: TOS) makes low-temperature sterilization technology for medical devices. Its president and CEO, Ric Rumble, said Mr. West’s more than 30 years in the health and life sciences sector will be valuable as the firm evaluates its U.S. listing options.
“He also has gained extensive global expertise from his tenure at Nordion, MDS and Unilever Canada, which we expect to help guide our fast-growing global business,” Mr. Rumble said in a statement.
OBJ360 (Sponsored)
Adapting to hybrid Work: How IAV Is simplifying office technology with BYOD solutions
You may have heard of BYOB, but have you heard of BYOD? BYOD, also known as “Bring your own device” is becoming a common practice for companies following hybrid work
Experience Canadian Culinary Excellence!
Every February, Ottawa turns into Canada’s culinary capital for the weekend. Chefs from across the country who have won their regional championships will converge on Ottawa Jan. 31 to Feb.
Mr. West, who also chairs the board of the Innovation Centre at Bayview Yards, said TSO3’s new sterilization product addresses an “unmet need” in hospitals and he looks forward to working with the firm to assist in the rollout of the product.
“TSO3 has clearly entered the commercialization stage of its development with the significant ramp in sales during the third quarter and completion of its new U.S. distribution and customer support facility,” he said in a statement.
In midday trading on the Toronto Stock Exchange, TSO3’s stock jumped six cents to $1.76. ’
